The use of hematopoietic cell transplantation (HCT) has risen in recent years and additional increases are projected in the near-and long-term future. The complex nature of HCT, along with its potentially rigorous follow-up care requirements, presents numerous potential barriers to accessing this important service (for example, financial considerations, donor availability and sociodemographic factors). The distance between a patient and an HCT facility also appears to be an important factor in both HCT use and outcomes. We provide the first comprehensive and detailed evaluation of geographic access to HCT services for the adult (18+ years) and pediatric (0-17 years) populations in the United States. Population-level access is examined as well as detailed gender, race/ethnicity and age breakdowns. Generally, access to HCT services appears to be quite high throughout the United States, as 48%, 78.6% and 94.7% of the 18+ years age population has 30, 90 and 180 min access (respectively) to an adult HCT facility and 42.5%, 72% and 91.5% of the 0-17 years age population has 30, 90 and 180 min access (respectively) to a pediatric facility.
INTRODUCTION
Hematopoietic cell transplantation (HCT) is a highly specialized treatment that requires a comprehensive and technologically sophisticated clinical infrastructure. For many patients facing life-threatening oncologic and hematologic diseases, HCT is the only known curative therapy. 1 Improvements in transplant outcomes because of better supportive care measures and better donor availability has allowed the use of HCT in a greater number of patients, resulting in steady increases in recent decades in the United States and worldwide; 2 each year in the United States, roughly 20 000 patients receive HCT 3 and continued growth is expected in the future. 4 Owing to the specialized nature of HCT, facilities that provide this important treatment are not commonplace in the United States (we identified 229 facilities that provide blood, marrow and/ or stem cell transplantation services in the conterminous United States, which includes the lower 48 states and Washington DC). As many of the HCT facilities are located in or near urban centers, residents living in rural regions must travel further than their urban counterparts to access these services. In addition to the geographic disparities in access, the complexity of interactions required among patient, provider and a health-care system in HCT likely create additional access barriers, 5 exacerbating disparities in geographic access to HCT services.
Allogeneic HCT requires rigorous and advanced posttransplantation care, thus geographic access may have a more important role than in other health-care services. For this treatment, the distance separating a patient and facility does not act as a simple 'one-time' barrier, but must continuously be overcome following transplantation. Patients living far from the HCT facility face the difficult decision of whether to transfer their posttransplant care to a non-specialist facility located closer to their residence, regularly travel the long distance for their follow-up care, or relocate nearer to the HCT facility for the duration of the posttransplantation period. Many HCT transplant centers require allogeneic transplant patients to relocate nearer to the facility for the first 100 days of post-transplant care. For autologous HCT patients, these concerns appear less salient, as most do not receive follow-up care at the HCT facility after discharge. 3 The spatial components of access to HCT services have been examined, albeit to a limited extent, in past academic literature. Specifically, patients with longer drive times (4160 min) to an HCT facility experienced worse outcomes than patients with shorter drive times, along with decreased post-treatment utilization of HCT facilities. 6 Other research suggests a greater posttransplant mortality risk for autologous transplant patients residing in rural regions (longer travel time to HCT service location) when compared with those from urban regions. 7, 8 The relatively small number of HCT facilities in the United States, in conjunction with the potential effects of geographic access on HCT utilization and outcomes, highlight the importance of understanding the current state of geographic access to HCT services. This research evaluates the status of potential geographic access to HCT facilities using national-level roads and population databases within a Geographic Information System. We provide the first highly detailed nationwide account of geographic access to HCT services for the US population.
MATERIALS AND METHODS

Study area
The study area for this analysis is the conterminous United States, which includes the lower 48 states and Washington DC (For purposes of simplicity, Washington DC is considered and referred to as a 'state'). Alaska and Hawaii were excluded due to their isolated locations, which present unique geographic accessibility problems not well captured in the nationwide analysis.
HCT locations
The street addresses and facility type (adult, pediatric, both) of 162 facilities providing HCT (bone marrow and/or stem cell) services were downloaded from the National Marrow Donor Program website (http://www.marrow. org). An additional list of 207 facilities was acquired from the Center for International Blood and Marrow Transplant Research (CIBMTR, http://www. cibmtr.org). Both facility lists were collected on 1 January 2015. Street addresses and facility types from the CIBMTR list were gathered via internet searches and telephone communication. Nine facilities were removed from the CIBMTR database, as location or contact information was unavailable. The two databases were consolidated to create a final list of 229 HCT facilities (118 adult only, 44 pediatric only and 67 adult/ pediatric). The facilities' street addresses were converted to latitude and longitude coordinates using Google's Geocoder API (https://developers. google.com/maps/documentation/geocoding/) within a custom-built R Population data 2010 US Census block group data (ftp://ftp2.census.gov/geo/tiger/ TIGER2010/ BG/2010/) were used as the population data (n = 215 491; mean block group population = 1423.14). This scale of analysis was determined after considering the requisite detail to provide useful results and the computational resources necessary to conduct a national-level analysis. Block group polygon features were converted to point centroids to reduce data processing time. Point centroids represent the geographic center of a block group.
Population demographic data for the block groups included age, gender and race/ethnicity categorical breakdowns (http://www2.census.gov/cen sus_2010/04-Summary_File_ 1/). Attribute data were joined to the centroid data, producing a file containing the point location and demographic information for every block group. Figure 1 shows the US population distribution.
Travel time
A network travel model was constructed from a roads database provided by Esri. Road attributes include a Functional Class value, describing general use and characteristics, and an Arterial Classification Code, describing travel mobility (traffic volume and length of trip). Roads were classified as urban or rural by spatially overlaying the features with city limit boundary data. Speed limits were assigned to each road using the Functional Class, Arterial Classification Code and urban/rural designation. 10 Supplementary Table 2 provides descriptive statistics for the US roads database.
To account for the likely reductions in travel speeds because of traffic control mechanisms and real-world travel experiences (for example, stop signs, traffic lights, traffic congestion) not represented in the roads database, an estimated travel speed was assigned to each road segment by subtracting 5 mph from the speed limit value. 10 A network travel time model was created using Network Analyst in ArcGIS Abbreviations: AIAN, American Indian or Alaska Native; HCT, hematopoietic cell transplantation; HWPI, Native Hawaiian or Other Pacific Islander and Multiple is Two or more races reported. For the access columns, the figures are in percent of the total group population. All minority populations entry includes the sum of all non-White populations.
(v 10.2, Redlands, CA, USA). In the network model, additional time delays were assigned for right-and left-hand turns. 30-, 60-, 90-, 120-, 150-and 180-min service areas were generated for all HCT facilities. This operation creates a polygon feature for every facility, such that the boundary of the polygon delineates the region where the facility can be reached within the specified travel time. For example, all locations within the bounds of a 30-min service area polygon can travel to the facility in 30 min or less, whereas locations outside the boundary cannot.
To determine population-level access, the block group population data were overlaid on the service area maps. For every block group falling within a service area (or service areas), the facility ID of the location was assigned to that block group. This procedure allowed for analysis of whether potential access is provided by an 'in-state' hospital or 'out-ofstate' hospital. Following the overlay process, the accessibility information was aggregated to state and national levels for further analysis.
RESULTS
A total of 229 facilities provide services for roughly 306 million people, an average of 1 HCT facility per 1.3 million people in the United States. Of the 229 HCT facilities, 185 provide adult services for the total US adult (18+ years) population of roughly 233 million In the United States, adults have slightly better overall geographic access than the pediatric population. Within the age categories, younger adults (18-29 and 30-44 years) appear to have the greatest geographic access to HCT services. However, variation within the age subgroups is not extreme. Geographic access was very similar for both males and females. Within the race/ethnicity subgroups, geographic access varied substantially for both adult and pediatric populations. Generally, the White population has the worst geographic access to HCT services (o 120 min) compared with minority populations (both aggregated and individually). However, these variations appear similar to the urban/rural distribution of the population subgroups and are a reflection of the urban-centric locations of HCT services. Tables 2 and 3 contain the state-by-state analysis of 30-180 min geographic access to HCT facilities. In Table 2 , access to 'any' HCT facility is considered. As this table shows, geographic access varies considerably from state to state. States without an HCT facility within their bounds have the lowest percentage of residents with access (especially for shorter travel times). The states with the lowest geographic access for adults are North Dakota and Nevada: 0% and 21.3% of these states' adult population can reach an HCT facility within 180 min, respectively. These two states also have limited access for their 0-17 population, with 0% (North Dakota) and 0.3% (Nevada) of the total 0-to 17-year olds having 180 min access to a pediatric facility. Considering 90 min travel for adult HCT services, Nevada and North Dakota are joined by Maine (2.4%) and Wyoming (2.2%) in having limited access. For 90 min travel to pediatric services, Nevada, North Dakota, South Dakota and Vermont all have 0% access. Maine (2.2%) and Wyoming (2.9%) also have limited 90 min access to pediatric HCT services for their population aged 0-17 years.
The states with the highest population-level geographic access to adult services are Arizona, Maryland, New Jersey, New York, Rhode Island and Washington DC, where more than 70% of state residents (aged 18+ years) are located within 30 min of an HCT facility. For 30-min access to pediatric services, Washington DC has the highest percentage at 100%, followed by New Jersey (70%), Maryland (69.9%) and New York (69.3%). For 90-min access to adult services, 11 states are above 90%. For 90-min access to pediatric services, seven states are above 90%. Figures 4 and 5 show the US-level geographic distribution of the adult and pediatric population located more than 180 min from the nearest appropriate HCT facility.
In Table 3 , only access provided to residents by 'in-state' HCT facilities is considered. Because there is no centralized health-care planning or regulatory mechanism in the United States (such as the National Health Service in England), these duties must be performed at a state level. Further, some health insurance plans only cover services for in-state providers. The state-to-state variation in geographic access to in-state HCT facilities is provided as an alternative to the national approach found in Table 2 .
Only Washington DC (100%) and Rhode Island (83.3%) provide 30 min access to adult HCT services for more than 80% of their age 18+ years population. Perhaps unsurprisingly, these are the two smallest geographic regions in the United States.
When considering 60 min access to adult services, the number of states greater than 80% of the population rises to seven. Again, these states are all relatively small, except New York, which has a large proportion of its population located within a semi-concentrated region near to New York City. At 90 min travel time to an adult HCT facility, 18 states have more than 80% population access. Four states do not have an adult HCT facility, with the two most populous being Nevada and Maine (both having populations greater than 1 million).
For in-state pediatric HCT services, only Washington DC (100%) provides more than 70% of its 0-17 years age population with 30 min access, although Massachusetts (67%) and New York (66.9%) are near this percentage. Geographic access improves dramatically when considering 60 min access to pediatric facilities; 12 states have more than 70% of their 0-17 years age population within this travel time. At 90-min travel time, 14 states have greater than 80% access with five states above 90%. Eleven states do not have a pediatric HCT facility within their boundaries, the most populous being Arkansas, Kansas and Nevada, each having a 0-17 years age population greater than 600 000.
DISCUSSION
Given the highly specialized nature of HCT and considerable infrastructure and personnel requirements to provide HCT services, we find that national-level geographic access is quite high in the United States. Over 60% of all residents can access an age-appropriate HCT facility within 1 h travel time, over 80% within 2 h and nearly 94% within 3 h. Considering that this level of geographic coverage is provided by only 229 facilities, they appear to be well-located, geographically.
Distance is a well-recognized deterrent to health-care service use. To ensure proper follow-up care, allogeneic HCT patients with limited geographic access must decide whether to make numerous long trips or relocate near the HCT facility, either of which can be a significant financial burden. Further, patients have shown increased unwillingness to travel long distances for post-transplant care, resulting in care being avoided or shifted to primary care physicians or oncologists located nearer to the patient, but having limited experience with transplant care. 7 For HCT, both the geographic and non-geographic components of access, as well as population and system-level factors, appear to have significant roles in both utilization and outcomes. Disparities in access to HCT services have been reported for minority and/or socially disadvantaged populations, 12, 13 as well as difficulties in securing a suitable donor 14 and limited evidence of worse overall outcomes after HCT. 13 Furthermore, patient sociodemographic characteristics such as age, gender and insurance status have also been shown to influence utilization of HCT services. 5 Additional barriers to accessing HCT include variation in physicians' referral patterns, 15 the availability of a suitable transplant donor for allogeneic HCT, 16 and securing payment for treatment via insurance coverage pre-approval or patient prepayment. 17 Our analysis did not include differences in hematologic disease incidence rates or HCT service needs among subpopulations. To overcome this limitation, we provide demographic breakdowns by level of geographic access. Recent similar work estimated potential demand and unmet need for HCT services throughout the United States using Geographic Information System-based methods. 18 Importantly, instead of assuming all people can access an HCT facility, we identified the level of geographic access.
We were unable to address differences in health insurance providers' stipulations regarding HCT. Some insurance companies require HCT patients to utilize specific types of facilities (for example, centers of excellence) or predetermined (contracted) facilities, which may require patients to bypass closer options and incur longer travel times. These particular practices could not be No centralized source provides comprehensive HCT facility data for the United States. Although we attempted to create an exhaustive database of HCT facilities, the analysis was limited by the available data. We assume that facilities providing HCT were not included in the analysis. The effect on geographic access is difficult to estimate, as their locations cannot be quantitatively or qualitatively approximated.
Each HCT facility was considered to have similar characteristics, in terms of services provided (allogeneic versus autologous), resource availability and quality. Although these factors influence patient decisions regarding treatment, we did not differentiate facilities in our analysis. This likely precipitates an overestimation of geographic access, as a large proportion of HCT recipients travel to receive care at high volume centers 3 and facilities offering only autologous HCT services are not suitable for patients requiring allogeneic HCT. Future work that integrates additional facility information (for example, FACT accreditation 19 ) with measures of geographic access could improve understanding of distance's role in HCT access and outcomes. Two further limitations in our study stem from the national-level travel analysis. First, we only consider vehicular-based travel. However, the expected number of HCT patients using alternate travel modes (for example, public transportation) is extremely low. Next, a single speed limit classification system was employed for the United States. Although speed limits are not consistent from state to state, we are confident our analysis captured the general nature of geographic access to HCT services throughout the United States. However, regional variations in precision are expected due to local travel conditions.
Although geographic access appears favorable in the United States, more than 12 million adults and 6 million children reside more than 180 min from the nearest age-appropriate HCT facility. Fifty million adults and slightly more than 20 million children reside more than 90 min from the nearest facility. Access to transplantation services is certainly influenced by geography; however, there are a multitude of additional factors that limit US pediatric population, greater than 180 minutes access Population 0-17 0 1 1,000 2,000 6,000 12,000 25,000 50,000 100,000 245,746 Figure 5 . Population (aged 0-17 years) located greater than 180 min from a pediatric HCT facility. Access to any (instate or out of state) HCT facility is considered. A full color version of this figure is available at the Bone Marrow Transplantation journal online.
access, including sociodemographic status, health insurance and resource availability. Therefore, simply opening up centers in regions having limited geographic access without additional resources available to meet these other unmet needs may not provide the expected benefits. Possible alternative approaches to alleviate the burden of distance for HCT patients with limited geographic access include developing HCT care outreach programs or telemedicine systems. These approaches have the potential to reduce post-transplant complications, improve post-transplant quality of life, and reduce financial burdens without the major investment required to open an HCT facility.
Further research is necessary to better understand how distance affects HCT access and outcomes. Additional information on population need, physician (and other necessary personnel) supply and the relative importance of spatial and non-spatial barriers is required to better evaluate overall access to this important service. Our analysis provides an initial step toward this goal. The decentralized nature of the US health-care system ensures that no 'top down' measures will be implemented to address geographic access to HCT. We encourage state policy makers, health-care professionals and researchers to seek out novel solutions to increase both the accessibility and availability of this important service.
